Por favor, use este identificador para citar o enlazar este ítem:
http://ciatej.repositorioinstitucional.mx/jspui/handle/1023/339| Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go? | |
| MARIO ALBERTO FLORES VALDEZ | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| ISSN: 2164-5515 http://www.tandfonline.com/loi/khvi20 | |
| clinical trials; multiantigenic; tuberculosis; vaccines | |
| The idea of presenting this commentary is to bring attention to the current status of clinical tests from several multiantigen vaccine candidates based on proteins produced by means of genetic engineering and molecular biology approaches and to suggest how new emerging technologies (OMICs) and bioinformatics might benefit vaccine development for better control of tuberculosis. | |
| Journal Human Vaccines & Immunotherapeutics | |
| 06-04-2016 | |
| Artículo | |
| Inglés | |
| Beneficiarios de fondos federales y solicitantes Bibliotecarios Empresas Estudiantes Investigadores Maestros Medios de comunicación Proveedores de fondos para estudiantes Público en general | |
| Guapillo, C., Hernández-Pando, R., & Flores-Valdez, M. A. (2016). Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go?. Human vaccines & immunotherapeutics, 1-3. | |
| MEDICINA Y CIENCIAS DE LA SALUD | |
| Aparece en las colecciones: | ARTICULOS |
Cargar archivos:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Guapillo Subunitary HVI2016.pdf | Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go? | 673.48 kB | Adobe PDF | Visualizar/Abrir |